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ABSTRACT
Introduction: There is a strong body of evidence
demonstrating the effectiveness of brief interventions
by primary care professionals for risky drinkers.
However, implementation levels remain low because of
time constraints and other factors. Facilitated access to
an alcohol reduction website offers primary care
professionals a time-saving alternative to standard
face-to-face intervention, but it is not known whether it
is as effective.
Methods and analysis: A randomised controlled
non-inferiority trial for risky drinkers comparing
facilitated access to a dedicated website with standard
face-to-face brief intervention to be conducted in
primary care settings in the Region of Friuli Giulia
Venezia, Italy. Adult patients will be given a leaflet
inviting them to log on to a website to complete the
Alcohol Use Disorders Identification Test (AUDIT-C)
alcohol screening questionnaire. Screen positives will
be requested to complete an online trial module
including consent, baseline assessment and
randomisation to either standard intervention by the
practitioner or facilitated access to an alcohol reduction
website. Follow-up assessment of risky drinking will be
undertaken online at 1 month, 3 months and 1 year
using the full AUDIT questionnaire. Proportions of
risky drinkers in each group will be calculated and
non-inferiority assessed against a specified margin of
10%. Assuming a reduction of 30% of risky drinkers
receiving standard intervention, 1000 patients will be
required to give 90% power to reject the null
hypothesis.
Ethics and dissemination: The protocol was
approved by the Isontina Independent Local Ethics
Committee on 14 June 2012. The findings of the
trial will be disseminated through peer-reviewed
journals, national and international conference
presentations and public events involving the local
administrations of the towns where the trial
participants are resident.
Registration details: Trial registration number NCT:
01638338.
BACKGROUND
Hazardous alcohol consumption is a signiﬁ-
cant public health problem, with an esti-
mated 3.8% of all global deaths and 4.6% of
global disability-adjusted life years lost attrib-
utable to alcohol.1 The European Union
(EU) is the heaviest drinking region in the
world, drinking an average of 11 litres of
pure alcohol per adult each year.2 In Region
Friuli Venezia Giulia, risky alcohol consump-
tion varies between 23.2% and 37.4% of the
general population, being more signiﬁcant
in young adults (18–24 years).3–6 There is
strong evidence that screening and brief
interventions (SBIs) are effective in reducing
both alcohol consumption and the harms
associated with hazardous drinking.7
However, in primary care, less than 10% of
hazardous and harmful drinkers are
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identiﬁed and less than 5% of those who could beneﬁt
are offered BIs.8 One of the principal reasons for this is
that conventional delivery of BI can add up to 15 min to
the primary consultation. In Italy, research on the topic
of SBI in general practice is scarce and although there is
some evidence about general practitioners’ (GPs’)
knowledge and attitudes,9 no evidence exists on the
extent to which SBIs are currently implemented.
The provision of facilitated access by primary care pro-
fessionals to an alcohol reduction website could signiﬁ-
cantly increase BI rates by offering a time-saving
alternative to face-to-face intervention. A review of trials
of computer-based interventions in college drinkers
found them to be more effective than no treatment and
as effective as alternative treatment approaches. The
recent online trial of Down Your Drink (http://www.
downyourdrink.org.uk/) indicated potentially signiﬁcant
reductions in alcohol consumption and risky drinking
behaviours in subjects who used the trial websites,10 and a
number of initiatives are underway to test the acceptabil-
ity of this approach.11 The EU-funded ODHIN trial cur-
rently underway in ﬁve European countries is designed to
determine the impact of facilitated access on levels of
implementation of BIs by primary care practitioners. The
DYD website has also been deployed in two NHS Primary
Care Trust settings in London, including the automated
baseline assessment of alcohol consumption and alcohol-
related problems together with facilitated access by
primary care professionals. The initial ﬁndings suggest
that facilitated access is both feasible and attractive in
primary care settings, but evidence is required to establish
whether it is as effective as standard intervention.
METHODS AND ANALYSIS
Trial design
Effectiveness of primary care based Facilitated Access to
alcohol Reduction website - a non-inferiority rando-
mized controlled trial-Friuli Venezia Giulia (EFAR-FVG)
is a primary care-based randomised controlled non-
inferiority trial comparing facilitated access to a dedi-
cated website for risky drinkers with standard face-to-face
BI. With the exception of the reference intervention, all
components of the trial will be delivered online to
patients who have been given a unique trial log-on
number by their general practice. Access will be through
the healthy lifestyle portal of the ofﬁcial website of the
Region of Friuli Venezia Giulia.
The trial website
The website is an Italian language online facility which
includes modules for all the key trial components includ-
ing screening, consent, assessment, randomisation and
follow-up. It also incorporates the alcohol reduction
website for the patients in the experimental group. The
site has been adapted from the www.DownYourDrink.org.
uk (DYD) website developed for the DYD-randomised
controlled trial (RCT) trial.10 Details of the DYD website
and the psychological theory which has underpinned its
development have been reported elsewhere.12
Country-speciﬁc information such as the recommended
guidelines for alcohol intake, deﬁnitions of standard
drinks and alcohol-related laws will be included. The
EFAR-FVG trial website will additionally incorporate a
menu-driven facility to enable the GPs to personalise the
automated patient messages by adding photographs of
themselves and audio/video recorded messages.
Practices
The trial will be conducted in primary care settings in
the Italian region of Friuli Venezia Giulia, and general
practices will be invited by email and letter to participate
in the study. Those expressing an interest in the trial
and a willingness to actively distribute the brochure invit-
ing patients to log on to the trial website will be consid-
ered for inclusion in the study. Preference will be given
to practices with at least 1000 registered patients and a
practice nurse and/or receptionist.
Training
All participating GPs will attend a 1-day training event
including an overview of the EFAR-FVG trial and inter-
active sessions on the delivery of face-to-face BI for risky
drinkers. Participants will be encouraged to familiarise
themselves with the trial website and will have the oppor-
tunity to use the menu-driven facility to create their own
tailored patient messages.
Patient eligibility
All patients aged 18 or over who attend the participating
practices during the study period will be eligible for the
trial. Patients over 80 and those suffering from severe psy-
chiatric disorder, serious visual impairment or terminal
illness will be excluded from the study, as will those judged
to have inadequate command of the Italian language.
Screening
Eligible patients will be encouraged by their GP or
another staff member to access a specially designed
healthy lifestyle website and will be given a trial brochure
providing a unique access number which will enable
them to log on. Once online, they will be asked to com-
plete the three-question short Alcohol Use Disorders
Identiﬁcation Test (AUDIT-C)13 and to provide agree-
ment to the result of the test to be sent to their practice.
For the purposes of the trial, cut points of 4 for women
and 5 for men will be used. Patients screening below the
cut points will receive an online message advising that
their responses indicate that their stated drinking pat-
terns fall within the guidelines for sensible drinking and
will be encouraged to maintain their current drinking
patterns. Those scoring at or above the cut points will
receive a personalised online message from their GP
advising that their stated drinking patterns indicate that
they are at risk from their drinking and inviting them to
take part in the study.
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Consent
Screen positive subjects will be asked to complete an
online form conﬁrming that they do not meet any of
the exclusion criteria and then be invited to complete
the online consent module. This provides information
about the trial and what will be requested of them as
participants. Those providing consent will be invited to
complete the online baseline assessment.
Baseline assessment
The baseline assessment includes the following:
1. A demographic questionnaire seeking information
on age, gender, level of education and occupation.
2. The 10-question AUDIT validated Italian version.14
3. D5-EQ D5 the quality-of-life questionnaire, validated
Italian version.15
Randomisation
Those completing the baseline questionnaires will
undergo automated online randomisation.
Experimental group—facilitated access to the alcohol
reduction website
Those in the experimental group will be taken to the
introductory page containing a personalised online
message from their GP with tailored feedback about
their responses to the alcohol questionnaires.
Personalised online messages from their GP will inform
patients of the importance of adopting healthy drinking
choices, and will encourage them to spend at least
15 min engaging with the alcohol reduction website in
the ﬁrst instance. Patients will receive an email 1 week
later encouraging them to log on again. They will also
be asked online to review their alcohol consumption
and be invited to discuss their website experience when
they next see their GP.
Reference group—face-to-face BI
Patients allocated to the standard intervention group
will be invited to check a box online which will automat-
ically generate an email to their practice requesting a
GP appointment for a face-to-face BI within the next 7–
10 days. At the appointment, the patient will receive an
intervention that will be based on the brief motivational
interview16:
1. Assessment of the motivation to change the risky
behaviour;
2. Assessment of the stage of change;
3. Advice—explicit advice on changing drinking
behaviour;
4. Empathy—role of counsellor is important;
5. Capacity building—instilling optimism that goals are
achievable.
Non-attenders will be offered up to three additional
appointments in order to optimise their intervention
rates.
Follow-up assessment
Follow-up will take place at 1, 3 and 12 months after ran-
domisation, and each assessment will consist of the
following:
1. The 10-question AUDIT validated Italian version.
2. D quality of life questionnaire, validated Italian
version 5—The EQ.
Every effort will be made to optimise response rates.
In the ﬁrst instance, each patient in the trial will receive
an automated email requesting them to login and com-
plete the assessment questionnaires. Failure to do so will
result in further emails at 1-week and 2-week intervals.
Persistent failure will be notiﬁed to the patient’s GP who
will contact them by letter, phone or in person in order
to ensure that their assessment is completed.
Statistical analysis
The principal outcome measure will be the proportion
of risky drinkers as classiﬁed by responses to the
AUDIT-10 question scale at 3 months following
randomisation.
In order to assess the non-inferiority of facilitated
access compared with face-to-face BI, the proportions of
risky drinkers in each group will be computed and com-
pared using generalised non-linear mixed models
accounting for general practices as random effects.
Facilitated access will be deemed not inferior to
face-to-face treatment at a one-sided α of 2.5% if the dif-
ference between the proportions of risky drinkers in the
facilitated access group and the face-to-face BI group is
below a speciﬁed margin of non-inferiority of 10%.
Assuming a reduction of 30% in the proportion of risky
drinkers in the face-to-face intervention group and
allowing for an overall attrition of 10% of patients in the
trial, it is calculated that 500 patients will be required in
each group to give the trial 90% power (1-β) to reject
the null hypothesis that facilitated access is inferior to
face-to face intervention. All analyses will be described
in a detailed statistical analysis plan which will be com-
pleted before unblinding and database lock.
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